Browse > Article
http://dx.doi.org/10.5483/BMBRep.2012.45.9.083

PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression  

Kim, Duk-Soo (Department of Anatomy, College of Medicine, Soonchunhyang University)
Sohn, Eun-Jeong (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Kim, Dae-Won (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Kim, Young-Nam (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Eom, Seon-Ae (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Yoon, Ga-Hyeon (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Cho, Sung-Woo (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Lee, Sang-Hyun (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Hwang, Hyun-Sook (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Cho, Yoon-Shin (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Park, Jin-Seu (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Eum, Won-Sik (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Choi, Soo-Young (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Publication Information
BMB Reports / v.45, no.9, 2012 , pp. 532-537 More about this Journal
Abstract
P18, a member of the INK4 family of cyclin-dependent kinase inhibitors, is a tumor suppressor protein and plays a key cell survival role in a variety of human cancers. Under pathophysiological conditions, the INK4 group proteins participate in novel biological functions associated with neuronal diseases and oxidative stress. Parkinson's disease (PD) is characterized by loss of dopaminergic neurons, and oxidative stress is important in its pathogenesis. Therefore, we examined the effects of PEP-1-p18 on oxidative stress-induced SH-SY5Y cells and in a PD mouse model. The transduced PEP-1-p18 markedly inhibited 1-methyl-4-phenyl pyridinium-induced SH-SY5Y cell death by inhibiting Bax expression levels and DNA fragmentation. Additionally, PEP-1-p18 prevented dopaminergic neuronal cell death in the substantia nigra of a 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-induced PD mouse model. These results indicate that PEP-1-p18 may be a useful therapeutic agent against various diseases and is a potential tool for treating PD.
Keywords
Cell viability; Parkinson's disease; PEP-1-p18; Protein therapy; Protein transduction;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
연도 인용수 순위
1 Choi, H. S., An, J. J., Kim, S. Y., Lee, S. H., Kim, D. W., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, H. J., Kang, J. H., Cho, S. W., Kwon, O. S., Park, J., Eum, W. S. and Choi, S. Y. (2006) PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radic. Biol. Med. 41, 1058-1068.   DOI   ScienceOn
2 Ahn, E. H., Kim, D. W., Kang, H. W., Shin, M. J., Won, M. H., Kim, J., Kim, D. J., Kwon, O. S., Kang, T. C., Han, K. H., Park, J., Eum, W. S. and Choi, S. Y. (2010) Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Toxicol. 276, 192-197.   DOI   ScienceOn
3 An, J. J., Lee, Y. P., Kim, S. Y., Lee, S. H., Lee, M. J., Jeong, M. S., Kim, D. W., Jang, S. H., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, O. S., Cho, S. W., Lee, K. S., Park, J., Eum, W. S. and Choi, S. Y. (2008) Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult. FEBS J. 275, 1296-1308.   DOI   ScienceOn
4 Kim, M. J., Kim, D. W., Yoo, K. Y., Sohn, E. J., Jeong, H. J., Kang, H. W., Shin, M. J., Ahn, J. J., Kwon, S. W., Kim, Y. N., Won, M. H., Cho, S. W., Park, J., Eum, W. S. and Choi, S. Y. (2010) Protective effects of transduced PEP-1-Frataxin protein on oxidative stress-induced neuronal cell death. J. Neurol. Sci. 298, 64-69.   DOI   ScienceOn
5 Morales-Garcia, J. A., Redondo, M., Alonso-Gil, S., Gil, C., Perex, C., Martinez, A., Santos, A. and Perez-Castillo, A. (2011) Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS ONE 6, e17240.   DOI   ScienceOn
6 Dauer, W. and Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889-909.   DOI   ScienceOn
7 Warner, T. T. and Schapira, A. H. (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 53, S16-S25.   DOI   ScienceOn
8 Eriksen, J. L., Przedborski, S. and Petrucelli, L. (2005) Gene dosage and pathogenesis of Parkinson's disease. Trends Mol. Med. 11, 91-96.   DOI   ScienceOn
9 Tasaki, Y., Omura, T., Yamada, T., Ohkubo, T., Suno, M., Iida, S., Sakaguchi, T., Asari, M., Shimizu, K. and Matsubara, K. (2010) Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells. Brain Res. 1344, 25-33.   DOI   ScienceOn
10 Subbareddy, M., Sudharsana, R. A., Soumya, P., Ted, P., Kazimierz, W., Anne, Z., Mehdi, E., Kamala, D. M., Emilia, W. and Marek, L. (2007) Cell survival, cell death and cell cycle pathway are interconnected: Implications for cancer therapy. Drug Resist. Updates 10, 13-29.   DOI   ScienceOn
11 Grant, S. and Roberts, J. D. (2003) The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy. Drug Resist. Updates 6, 15-26.   DOI   ScienceOn
12 Schwartz, G. K. and Shah, M. A. (2005) Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421.   DOI   ScienceOn
13 Eduardo, T. C., Maria, E. S., Julieta, M. C., Mariela, C. M., Abel, L. C., Pablo, F. S. and Maria, F. O. (2007) INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59, 419-426.   DOI   ScienceOn
14 Bradford, M. A. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.   DOI   ScienceOn
15 Dawson, T. M. and Dawson, V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.   DOI   ScienceOn
16 Eriksen, J. L., Wszolek, Z. and Petrucelli, L. (2005) Molecular pathogenesis of Parkinson disease. Arch. Neurol. 62, 353-357.   DOI   ScienceOn
17 Maddika, S., Mendoza, F. J., Fauff, K., Zamzow, C. R., Paranjothy, T. and Los, M. (2006) Cancer-selective therapy of the further: apoptin and its mechanism of action. Cancer Biol. Ther. 5, 10-19.   DOI
18 Deng, X., Gao, F. and May JR, W. S. (2003) Bcl-2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 102, 3179-3185.   DOI   ScienceOn
19 Araki, T., Mikami, T., Tanji, H., Matsubara, M., Imai, Y., Mizugaki, M. and Itoyama, Y. (2001). Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. Eur. J. Pharm. Sci. 12, 231-238.   DOI   ScienceOn
20 Lee, S. H., Kim, D. W., Back, S. S., Hwang, H. S., Park, E. Y., Kang, T. C., Kwon, O. S., Park, J. H., Cho, S. W., Han, K. H., Park, J., Eum, W. S. and Choi, S. Y. (2011) Transduced Tat-annexin protein suppresses inflammation-associated gene expression in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells. BMB Rep. 44, 484-489.   DOI   ScienceOn
21 Shin, M. J., Lee, Y. P., Kim, D. W., An, J. J., Jang, S. H., Cho, S. M., Sheen, S. H., Lee, H. R., Kweon, H. Y., Kang, S. W., Lee, K. G., Park, J., Eum, W. S., Cho, Y. J. and Choi, S. Y. (2010) Transduced PEP-1-AMPK inhibits the LPS-induced expression of COX-2 and iNOS in Raw 264.7 cells. BMB Rep. 43, 40-45.   DOI   ScienceOn
22 Egleton, R. D. and Davis, T. P. (1997) Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18, 1431-1439.   DOI   ScienceOn
23 Dietz, G. P. (2010) Cell-penetrating peptide technology to delivery chaperones and associated factors in diseases and basic research. Curr. Pharm. Biotechnol. 11, 167-174.   DOI   ScienceOn
24 Finkel, E. (2001) The mitochondrian: is it central to apoptosis? Science 292, 624-626.   DOI
25 Kim, S. Y., Kim, M. Y., Mo, J. S., Park, J. W. and Park, H. S. (2007) SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion ($MPP^+$)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling. Neurosci. Lett. 413, 132-136.   DOI   ScienceOn
26 Chung, Y. C., Ko, H. W., Bok, E., Park, E. S., Huh, S. H., Nam, J. H. and Jin, B. K. (2010) The role of neuroinflammation on the pathogenesis of Parkinson's disease. BMB Rep. 43, 225-232.   DOI   ScienceOn
27 Brouckaert, G., Kalai, M., Saelens, X. and Vandenabeels, P. (2005) Apoptotic pathways and their regulation. In: Los, M., Gibson. S. B. (eds.), Apoptotic pathway as target for novel therapies in cancer and other diseases. Springer Academic Press, New York, USA.
28 Wadia, J. S. and Dowdy, S. F. (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13, 52-56.   DOI   ScienceOn
29 Morris, M. C., Depollier, J., Mery, J., Heitz, F. and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173-1176.   DOI   ScienceOn
30 Eum, W. S., Kim, D. W., Hwang, I. K., Yoo, K. Y., Kang, T. C., Jang, S. H., Choi, H. S., Choi, S. H., Kim, Y. H., Kim, S. Y., Kwon, H. Y., Kang, J. H., Kwon, O. S., Cho, S. W., Lee, K. S., Park, J., Won, M. H. and Choi, S. Y. (2004) In vivo protein transduction: Biologically active intact PEP-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 37, 1656-1669.   DOI   ScienceOn